287
Participants
Start Date
September 15, 2006
Primary Completion Date
February 11, 2008
Study Completion Date
February 11, 2008
RN624 (PF-04383119)
50 mcg/kg
AAIR Research Center, Rochester
Altoona Center for Clinical Research, Duncansville
The Center for Rheumatology and Bone Research, Wheaton
Charlottesville Medical Research, Charlottesville
Sports Medicine and Orthopaedics Center, Greensboro
Pharmquest, Greensboro
Covance Clinical Research Unit, Inc, Daytona Beach
Habana Hospital Pharmacy, Tampa
BrookWood Internal Medicine, Birmingham
Radiant Research, Birmingham
New Orleans Center for Clinical Research, Knoxville
Volunteer Research Group, Knoxville
Office of David Neustadt, PSL, Louisville
Pharmacotherapy Research Associates Incorporated, Zanesville
Northwest Indiana Center for Clinical Research, Merrillville
Center for Pharmaceutical Research, P.C., Kansas City
Quality Clincal Research, Omaha
Radiant Research - San Antonio, San Antonio
Radiant Research San Antonio Northeast, San Antonio
Rheumatology Associates of South Texas, San Antonio
South Texas Radiology Imaging Center, San Antonio
Office of Walter F. Chase, MD, PA, Austin
Covance Boise, Boise
Pivotal Research, Midvale
Arizona Research Center, LLC, Phoenix
Albuquerque Clinical Trials, Albuquerque
Synergy Clinical Research Center, National City
Imaging Centers of Anaheim, Anaheim
Orange County Clinical Research, Anaheim
Covance Clinical Research Unit, Inc. Honolulu, Honolulu
Clinical Trials Northwest, Yakima
David M. Radin, MD, Stamford
Stamford Therapeutics Consortium, Stamford
Ocala Rheumatology Research Center, Ocala
Tampa Medical Group, PA, Tampa
Clinical Pharmacology Study Group, Worcester
Lead Sponsor
Pfizer
INDUSTRY